Clinical trial
Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by…
NCT00358657 · Fred Hutchinson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00358657 |
|---|---|
| Title | Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders |
| Official title | HLA-Haploidentical Related Marrow Grafts for the Treatment of Primary Immunodeficiencies and Other Nonmalignant Disorders Using Conditioning With Low-Dose Cyclophosphamide, TBI and Fludarabine and Postgrafting Cyclophosphamide |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH National Heart, Lung, and Blood Institute (NHLBI) |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Immunodeficiency Syndrome, Severe Aplastic Anemia, Genetic Disorder |
| Intervention type | Drug, Other, Procedure, Radiation |
| Interventions | Allogeneic Bone Marrow Transplantation, Cyclophosphamide, Fludarabine Phosphate, Laboratory Biomarker Analysis, Mycophenolate Mofetil, Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation, Sirolimus, Tacrolimus, Total-Body Irradiation |
| Enrollment | 14 |
| Start date | May 24, 2006 |
| Primary completion | Aug 17, 2018 |
| Completion | May 25, 2019 |
| First posted | Aug 1, 2006 |
| Last update posted | Jan 26, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: